Ledger.Open graph →
SEC Form D · filed December 5, 2016

Apexian Pharmaceuticals, Inc

Offering
$1.5M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
INDIANAPOLIS, IN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

David R. Broecker · Indianapolis, INDirectorRoger R. Miller · Indianapolis, INExecMark R. Kelly, Phd · Indianapolis, INExec · DirectorHomer R. Pearce · Indianapolis, INDirectorMartin R. Haslanger, Phd · Indianapolis, INDirectorJohn R. Barnard · Indianapolis, INDirectorCharles F. Gillies · Woburn, MADirectorBrian Anderson · Birmingham, ALExec · DirectorHasan Ansari · New Haven, CTDirectorSteve Carchedi · San Antonio, TXExec · DirectorYulia Khvan · New Haven, CTDirectorFanni Li · New Haven, CTExec · DirectorSrikar Prasad · New Haven, CTExec · DirectorKrish Panu · ALAMEDA, CADirectorKenny Lin · Las Vegas, NVDirectorMerav Resistal · Greenwich, CTExecSteve Carchedi · Indianapolis, INExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗